Product Availability Alert
HPS Pharmacies wish to advise that Janssen have given notice of an interruption to supply of the following:
|Contents||alfentanil 0.5mg/mL||fentanyl 0.05mg/mL|
|Presentation||5 x 2mL injection||10 x 2mL injection|
|Estimated arrival of next batch||Early February 2014||Early February 2014|
The supply interruption is due to difficulties in manufacture, and may result in intermittent shortages until June 2014. There are no concerns regarding the safety or quality of these products.
Supplies of Rapifen® (alfentanil) 0.5mg/mL x 2mL are already exhausted, and prescribing alternative opioids, such as remifentanil or fentanyl, are recommended. Sufficient quantities of the alternative presentation, Rapifen® (alfentanil) 5mg/10mL, are available to meet current needs.
Several alternative brands are available in place of Sublimaze® (fentanyl) 0.05mg/mL; a shortage of fentanyl is not expected.
Please retain this notice in a prominent position, including other related business units as a reminder for all staff members until normal supply resumes.
Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies or Janssen Medical Information on 1800 226 334.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.